Bark, Inc. (BARK): Nasdaq/NYSE listing notice — BARK receives NYSE non-compliance notice for stock price below $1.00; has six-month cure period

Bark, Inc.

NYSE notified BARK on Nov 22, 2023, that avg closing price was below $1.00 for 30 trading days ended Nov 21, 2023.
BARK has six months to regain compliance via closing price and 30-day avg of at least $1.00 on last trading day of a month.
BARK considering options including a reverse stock split (subject to stockholder approval) to cure the deficiency.
Stock continues trading on NYSE during cure period; no immediate impact on operations or SEC reporting requirements.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Bark, Inc. received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

Exchange: nyse
Notice: noncompliance notice
Deficiency: minimum bid price
Rules: 802.01C

Exact text from the filing

November 22, 2023, BARK, Inc. (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s common stock was less than $1.00 per share over a consecutive 30 trading-day period ended November 21, 2023. The Notice does not result in the immediate delisting of the Company’s common stock from the NYSE. In accordance with applicable NYSE rules, the Company has no

View on SEC.gov

95 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Bark, Inc. filing history →

Source: SEC EDGAR

accession 0001819574-23-000045

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.